Plain-English translation of NCT07089602 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether human placental membrane wraps—specially processed tissues from donated placentas—can help stubborn diabetic foot ulcers and leg ulcers heal better when used alongside standard wound care. Researchers will compare four different versions of these membrane wraps (with different thicknesses and features) against standard care alone. The goal is to see if adding this membrane treatment speeds up healing and closes these wounds more completely.
Many diabetic foot ulcers and leg ulcers refuse to heal with regular wound care alone, sometimes staying open for months or years and increasing the risk of serious infection or amputation. This trial exists to find out whether this medication can give wounds the extra healing boost they need.
You likely qualify if…
You likely don't qualify if…
If you join, you'll visit the study center weekly for up to 12 weeks or until your ulcer completely closes. At each visit, your wound will be measured and photographed, and you'll receive a fresh application of either the placental membrane wrap plus standard dressing, or standard dressing alone (depending on which group you're assigned to). You'll also need to use an off-loading boot or compression wrap as directed and commit to attending all scheduled appointments.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States